The post New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development appeared on BitcoinEthereumNews.com. Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books. FORBES BOOKS NEW YORK (November 18, 2025) — Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes. In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it. The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel. Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research. “While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must… The post New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development appeared on BitcoinEthereumNews.com. Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books. FORBES BOOKS NEW YORK (November 18, 2025) — Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes. In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it. The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel. Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research. “While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must…

New Book Shows How The Right Culture And Strategy Drive Breakthroughs In Drug And Device Development

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Gary K. Zammit, PhD, releases “Beyond the Science” with Forbes Books.

FORBES BOOKS

NEW YORK (November 18, 2025)Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences by Gary K. Zammit, PhD, is now available on Amazon and at major booksellers. The book is published with Forbes Books, the exclusive business book publishing imprint of Forbes.

In Beyond the Science, Gary Zammit, an award-winning entrepreneur and founder of Clinilabs, offers an insider’s guide to what makes clinical research organizations thrive or fail. Backed by over twenty-five years of experience, Dr. Zammit reveals how the success of drug and device development depends not only on innovative science but also on the people, processes, and systems behind it.

The book shares Dr. Zammit’s experience building Clinilabs, a specialty contract research organization dedicated to central nervous system therapeutics. Readers follow the company’s story from its early struggles through near-collapse during the Great Recession to its emergence as a highly respected industry leader. Along the way, Dr. Zammit emphasizes that true breakthroughs require assembling teams of “A-players,” creating processes that blend scientific rigor with practical efficiency, and leveraging systems that enable people to excel.

Structured in two parts, the book first examines how leaders can foster cultures that inspire innovation, collaboration, and integrity. In the second part, Dr. Zammit outlines the operational frameworks that drive excellence in clinical trials from risk mitigation and compliance to integrating new technologies. Combining his hard-earned lessons with insights from industry peers, Dr. Zammit’s compendium assembles leaders and entrepreneurs committed to pushing the boundaries of medical research.

“While this book focuses on the life sciences—the industry I know—I believe that the concepts presented can be applied to just about any business enterprise,” Dr. Zammit said. “In the end, people, processes, and systems must work together seamlessly for greatness to be possible.”

At its core, Beyond the Science argues that R&D must be more than research and development—it must also be about revolt and disruption.

This release is posted on behalf of Forbes Books (operated by Advantage Media Group under license).

About the Author

Gary Zammit, PhD, is founder and CEO of Clinilabs, and an award-winning entrepreneur and expert in neuropsychiatric drug development and sleep medicine. A clinical professor at the Icahn School of Medicine at Mount Sinai and Fellow of the American Academy of Sleep Medicine, he has dedicated his career to developing better treatments for patients with psychiatric and neurological disorders.

About Forbes Books

Founded in 2016 in partnership with Advantage Media Group, Forbes Books is the exclusive book publishing imprint of Forbes Media. Forbes Books offers business and thought leaders a way to share their ideas and expertise with the world. Authors are carefully vetted to ensure their stories and insights align with the Forbes mission of driving success through innovation and entrepreneurial thinking. For more information, visit books.forbes.com.

Forbes Books Media Contact: Tate Causey, [email protected]

Source: https://www.forbes.com/sites/forbes-books-news/2025/11/18/new-book-shows-how-the-right-culture-and-strategy-drive-breakthroughs-in-drug-and-device-development/

Market Opportunity
ConstitutionDAO Logo
ConstitutionDAO Price(PEOPLE)
$0.006618
$0.006618$0.006618
+0.44%
USD
ConstitutionDAO (PEOPLE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Polygon Tops RWA Rankings With $1.1B in Tokenized Assets

Polygon Tops RWA Rankings With $1.1B in Tokenized Assets

The post Polygon Tops RWA Rankings With $1.1B in Tokenized Assets appeared on BitcoinEthereumNews.com. Key Notes A new report from Dune and RWA.xyz highlights Polygon’s role in the growing RWA sector. Polygon PoS currently holds $1.13 billion in RWA Total Value Locked (TVL) across 269 assets. The network holds a 62% market share of tokenized global bonds, driven by European money market funds. The Polygon POL $0.25 24h volatility: 1.4% Market cap: $2.64 B Vol. 24h: $106.17 M network is securing a significant position in the rapidly growing tokenization space, now holding over $1.13 billion in total value locked (TVL) from Real World Assets (RWAs). This development comes as the network continues to evolve, recently deploying its major “Rio” upgrade on the Amoy testnet to enhance future scaling capabilities. This information comes from a new joint report on the state of the RWA market published on Sept. 17 by blockchain analytics firm Dune and data platform RWA.xyz. The focus on RWAs is intensifying across the industry, coinciding with events like the ongoing Real-World Asset Summit in New York. Sandeep Nailwal, CEO of the Polygon Foundation, highlighted the findings via a post on X, noting that the TVL is spread across 269 assets and 2,900 holders on the Polygon PoS chain. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 Key Trends From the 2025 RWA Report The joint publication, titled “RWA REPORT 2025,” offers a comprehensive look into the tokenized asset landscape, which it states has grown 224% since the start of 2024. The report identifies several key trends driving this expansion. According to…
Share
BitcoinEthereumNews2025/09/18 00:40
World Gold Council’s Pivotal Framework Promises Unprecedented Market Trust

World Gold Council’s Pivotal Framework Promises Unprecedented Market Trust

The post World Gold Council’s Pivotal Framework Promises Unprecedented Market Trust appeared on BitcoinEthereumNews.com. Tokenized Gold Revolution: World Gold Council
Share
BitcoinEthereumNews2026/03/20 03:58
How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings

How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings

The post How to earn from cloud mining: IeByte’s upgraded auto-cloud mining platform unlocks genuine passive earnings appeared on BitcoinEthereumNews.com. contributor Posted: September 17, 2025 As digital assets continue to reshape global finance, cloud mining has become one of the most effective ways for investors to generate stable passive income. Addressing the growing demand for simplicity, security, and profitability, IeByte has officially upgraded its fully automated cloud mining platform, empowering both beginners and experienced investors to earn Bitcoin, Dogecoin, and other mainstream cryptocurrencies without the need for hardware or technical expertise. Why cloud mining in 2025? Traditional crypto mining requires expensive hardware, high electricity costs, and constant maintenance. In 2025, with blockchain networks becoming more competitive, these barriers have grown even higher. Cloud mining solves this by allowing users to lease professional mining power remotely, eliminating the upfront costs and complexity. IeByte stands at the forefront of this transformation, offering investors a transparent and seamless path to daily earnings. IeByte’s upgraded auto-cloud mining platform With its latest upgrade, IeByte introduces: Full Automation: Mining contracts can be activated in just one click, with all processes handled by IeByte’s servers. Enhanced Security: Bank-grade encryption, cold wallets, and real-time monitoring protect every transaction. Scalable Options: From starter packages to high-level investment contracts, investors can choose the plan that matches their goals. Global Reach: Already trusted by users in over 100 countries. Mining contracts for 2025 IeByte offers a wide range of contracts tailored for every investor level. From entry-level plans with daily returns to premium high-yield packages, the platform ensures maximum accessibility. Contract Type Duration Price Daily Reward Total Earnings (Principal + Profit) Starter Contract 1 Day $200 $6 $200 + $6 + $10 bonus Bronze Basic Contract 2 Days $500 $13.5 $500 + $27 Bronze Basic Contract 3 Days $1,200 $36 $1,200 + $108 Silver Advanced Contract 1 Day $5,000 $175 $5,000 + $175 Silver Advanced Contract 2 Days $8,000 $320 $8,000 + $640 Silver…
Share
BitcoinEthereumNews2025/09/17 23:48